dihexa hgf c-met mechanism Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity Design and Synthesis of c-Met
Design and Synthesis of c Met and HDAC Dual Inhibitors for the Treatment of Breast Cancer ACS Medicinal Chemistry Letters Downstream signalling and specific inhibition of c MET HGF pathway in small cell lung cancer: implications for tumour invasion British Journal of Cancer dihexa hgf c met agonist Artificial human Met agonists based on macrocycle scaffolds HGF c MET Signaling in Melanocytes and Melanoma
Pay in 4 interest-free payments of $7.23 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20



